Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$373M |
| 2 |
Costco
COST
|
+$283M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$270M |
| 4 |
Pfizer
PFE
|
+$240M |
| 5 |
Microsoft
MSFT
|
+$225M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$274M |
| 2 |
EMC CORPORATION
EMC
|
+$228M |
| 3 |
GAS
AGL Resources Inc
GAS
|
+$216M |
| 4 |
TECO ENERGY INC
TE
|
+$136M |
| 5 |
Charter Communications
CHTR
|
+$133M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.75% |
| 2 | Healthcare | 13.12% |
| 3 | Financials | 12.46% |
| 4 | Consumer Staples | 9.7% |
| 5 | Industrials | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1801
Brunswick
BC
$3.98B
| $3.67M | 0.01% |
75,300
+7,100
| +10% | +$339K |
2015 Q4
3 quarters
|
|
|
PTLA
1802
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $3.67M | 0.01% |
161,500
-187,900
| -54% | -$4.41M |
2015 Q1
6 quarters
|
|
|
EXA
1803
DELISTED
EXA Corporation
EXA
| $3.66M | 0.01% |
228,000
+46,400
| +26% | +$698K |
2013 Q4
11 quarters
|
|
|
FBNK
1804
DELISTED
First Connecticut Bancorp, Inc
FBNK
| $3.66M | 0.01% |
205,500
+8,600
| +4% | +$146K |
2013 Q2
13 quarters
|
|
1805
Churchill Downs
CHDN
$5.57B
| $3.65M | 0.01% |
149,850
-400,800
| -73% | -$9.44M |
2014 Q3
8 quarters
|
|
1806
Kimball Electronics
KE
$688M
| $3.65M | 0.01% |
263,675
+15,600
| +6% | +$194K |
2014 Q4
7 quarters
|
|
|
AVHI
1807
DELISTED
A V Homes, Inc.
AVHI
| $3.65M | 0.01% |
219,400
+35,000
| +19% | +$503K |
2013 Q2
13 quarters
|
|
|
CRAY
1808
DELISTED
Cray, Inc.
CRAY
| $3.65M | 0.01% |
154,951
-35,000
| -18% | -$893K |
2016 Q1
2 quarters
|
|
1809
Clearwater Paper
CLW
$306M
| $3.65M | 0.01% |
56,400
+18,200
| +48% | +$1.15M |
2015 Q2
5 quarters
|
|
1810
Seres Therapeutics
MCRB
$27.2M
| $3.64M | 0.01% |
+14,825
| New | +$5.2M |
2016 Q3
0 quarters
|
|
1811
LeMaitre Vascular
LMAT
$1.85B
| $3.64M | 0.01% |
183,500
+84,200
| +85% | +$1.47M |
2014 Q1
10 quarters
|
|
1812
Corcept Therapeutics
CORT
$13.1B
| $3.64M | 0.01% |
560,000
+249,400
| +80% | +$1.45M |
2015 Q1
6 quarters
|
|
1813
DELISTED
Town Sports International Holdings, Inc.
CLUB
| $3.64M | 0.01% |
1,177,941
+47,441
| +4% | +$132K |
2013 Q2
13 quarters
|
|
1814
Suburban Propane Partners
SPH
$1.14B
| $3.63M | 0.01% |
109,167
-96,200
| -47% | -$3.24M |
2013 Q4
11 quarters
|
|
1815
James River Group Holdings
JRVR
$168M
| $3.63M | 0.01% |
100,400
-10,900
| -10% | -$383K |
2015 Q3
4 quarters
|
|
1816
Silicon Laboratories
SLAB
$7.41B
| $3.63M | 0.01% |
61,800
-29,498
| -32% | -$1.59M |
2016 Q1
2 quarters
|
|
1817
Evolent Health
EVH
$457M
| $3.62M | 0.01% |
+146,900
| New | +$3.43M |
2016 Q3
0 quarters
|
|
1818
RBC Bearings
RBC
$15.9B
| $3.6M | 0.01% |
47,000
+17,500
| +59% | +$1.34M |
2016 Q2
1 quarter
|
|
1819
DELISTED
Tupperware Brands Corporation
TUP
| $3.59M | 0.01% |
+54,900
| New | +$3.45M |
2016 Q3
0 quarters
|
|
1820
NiSource
NI
$19.5B
| $3.58M | 0.01% |
+148,400
| New | +$3.71M |
2016 Q3
0 quarters
|
|
|
FGH
1821
DELISTED
FG Group Holdings Inc.
FGH
| $3.58M | 0.01% |
510,900
+37,405
| +8% | +$215K |
2013 Q2
13 quarters
|
|
|
GCAP
1822
DELISTED
Gain Capital Holdings, Inc.
GCAP
| $3.57M | 0.01% |
577,600
+94,900
| +20% | +$618K |
2014 Q2
9 quarters
|
|
1823
Superior Group of Companies
SGC
$208M
| $3.56M | 0.01% |
180,100
-15,000
| -8% | -$269K |
2013 Q2
13 quarters
|
|
|
ARQL
1824
DELISTED
Arqule Inc
ARQL
| $3.56M | 0.01% |
1,990,700
-37,883
| -2% | -$60.1K |
2013 Q2
13 quarters
|
|
1825
Home Bancorp
HBCP
$517M
| $3.56M | 0.01% |
127,214
-13,172
| -9% | -$374K |
2013 Q2
13 quarters
|
|
Similar funds
Renaissance Technologies's Q3 2016 Portfolio in Review
As of Q3 2016, Renaissance Technologies held 3,713 positions worth $56.6B, up 7.7% from $52.5B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Renaissance Technologies deployed $1.92B of net new capital in Q3 2016, opening 413 new positions and adding to 1,833 existing holdings. Its largest new stake was FedEx: 811,400 shares worth $142M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was CVS Health, an estimated $274M trimmed.
- Renaissance Technologies's largest Q3 2016 buy was FedEx: 811,400 shares worth $142M.
- Renaissance Technologies added most to Alphabet (Google) Class A in Q3 2016, an estimated $373M increase.
- Renaissance Technologies's biggest Q3 2016 reduction was CVS Health, cutting an estimated $274M.
- Renaissance Technologies fully exited EMC CORPORATION in Q3 2016, selling an estimated $228M.
- Renaissance Technologies's ten largest holdings make up 7.9% of its $56.6B portfolio in Q3 2016.
- Renaissance Technologies opened 413 new positions and closed 416 in Q3 2016.
- Renaissance Technologies's portfolio value rose 7.7% quarter-over-quarter to $56.6B.
Based on Renaissance Technologies's 13F filing for Q3 2016, filed 14 Nov 2016.